ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,251Medicare Part D Prescriptions Filled, Including Refills

Rank: 2 out of 26

$501K Total Retail Price of All Prescriptions

Rank: 2 out of 26

333 Patients Receiving at Least One Drug in Part D
89%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 7,475 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 350 339 1 5
HYDROCHLOROTHIAZIDE 306 290 2 8
LEVOTHYROXINE SODIUM 245 239 3 14
ATENOLOL 239 224 4 15
LISINOPRIL 204 185 5 2
DIOVAN 181 177 6 12
ALLOPURINOL 168 154 7 13
METOPROLOL SUCCINATE 163 159 8 16
OMEPRAZOLE 160 142 9 9
FUROSEMIDE 159 111 10 3
CITALOPRAM HBR 149 148 11 23
ATORVASTATIN CALCIUM 144 135 12 18
METOPROLOL TARTRATE 143 139 13 4
AMLODIPINE BESYLATE 140 128 14 1
LOSARTAN POTASSIUM 134 108 15 6
FELODIPINE ER 117 117 16 61
QUINAPRIL HCL 103 96 17 27
ZETIA 100 92 18 65
FLUOXETINE HCL 98 92 19 67
TAMSULOSIN HCL 97 95 20 34
PREDNISONE 95 87 21 17
DOXAZOSIN MESYLATE 94 83 22 7
CARVEDILOL 92 91 23 28
SPIRONOLACTONE 87 69 24 25
CLOTRIMAZOLE 86 85 25 72
COLCRYS 85 74 26 75
PANTOPRAZOLE SODIUM 84 61 27 57
POTASSIUM CHLORIDE 82 78 28 55
WARFARIN SODIUM 82 82 28 10
ALENDRONATE SODIUM 79 73 30 37
TRAZODONE HCL 72 66 31 19
LABETALOL HCL 72 65 31 22
JANUVIA 68 68 33 59
CALCITRIOL 67 49 34 11
CLOPIDOGREL 67 65 34 49
SYNTHROID 67 67 34 85
GABAPENTIN 66 49 37 26
CALCIUM ACETATE 61 53 38 31
RANITIDINE HCL 61 61 38 44
METFORMIN HCL 60 48 40 50
PRAVASTATIN SODIUM 60 45 40 24
GLYBURIDE 58 55 R 42 104
DIGOXIN 58 56 42 43
DONEPEZIL HCL 58 58 42 36
PROPRANOLOL HCL 57 57 45 107
ZOLPIDEM TARTRATE 55 43 46 40
WELCHOL 52 48 47 115
BACTROBAN 52 41 47 115
IRBESARTAN 52 44 47 115
KLOR-CON M20 51 49 50 45
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.